Kineret is a prescription drug that is used for treating rheumatoid arthritis in people who have not responded well to other medications. It can also treat neonatal-onset multisystem inflammatory disease. The medication is given as a daily injection, either by you or a healthcare provider. Side effects may include nausea, headache, and diarrhea.
People with rheumatoid arthritis often have high levels of a certain protein called interleukin-1 (IL-1) in their joints. IL-1 causes inflammation, cartilage damage, and bone erosion. Kineret is a synthetic form of a different naturally occurring protein in the body that inhibits the effects of IL-1. By binding to IL-1, Kineret can help reduce the symptoms of rheumatoid arthritis, along with the physical damage to the joints.
Kineret works to treat NOMID in the same manner (by inhibiting the inflammatory IL-1 protein).
Because Kineret targets a specific part of the immune system (IL-1), it is called a "biological response modifier" because it changes (modifies) the body's immune response. It is also known as a "biologic" medication, because it is a protein.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Kineret [package insert]. Stockholm, Sweden: Swedish Orphan Biovitrum;2012 December.
National Institutes of Health. Drug halts organ damage in inflammatory genetic disorder: NIH study shows benefits of long-term Kineret therapy in people with NOMID (February 10, 2013). NIH Web site. Available at: http://www.niams.nih.gov/News_and_Events/Press_Releases/2012/2_10.asp. Accessed February 24, 2013.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click